UNIGE document Scientific Article
previous document  unige:35601  next document
add to browser collection

Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients

Rezgui, MA
Théoret, Y
Mezziani, S
Vachon, MF
Desjean, C
show hidden authors show all authors [1 - 15]
Published in Bone Marrow Transplantation. 2013, vol. 48, no. 7, p. 939-46
Abstract BU is a key compound of conditioning regimens in children undergoing hematopoietic SCT (HSCT). Inter-individual differences in BU pharmacokinetics (PKs) might affect BU efficacy and toxicity. As BU is mainly metabolized by glutathione S-transferase (GST), we investigated the relationship between GSTA1, GSTM1 and GSTP1 genotypes with first-dose BU PKs, and the relationship with HSCT outcomes in 69 children receiving myeloablative conditioning regimen. GSTM1 null genotype correlated with higher BU exposure and lower clearance in patients older than 4 years (P ≤ 0.04). In accordance with the suggested functional role, GSTA1*A2 haplotype was associated with lower drug levels and higher drug clearance (P ≤ 0.03). Gene-dosage effect was also observed (P ≤ 0.007). GSTA1 haplotypes were associated with HSCT outcomes. Patients with two copies of haplotype *A2 had better event free survival (P=0.03). In contrast, homozygous individuals for haplotypes *B and *B1 had higher occurrence of veno-occlusive disease (P=0.009). GSTM1 null individuals older than 4 years had more frequently graft versus host disease (P=0.03). In conclusion, we showed that GST gene variants influence BU PK and outcomes of HSCT in children. A model for the dosage adjustment with the inclusion of genetic and non-genetic factors should be evaluated in a future prospective validation cohort.
Keywords AdultAge FactorsAllograftsBusulfan/administration & dosage/pharmacokineticsChildChild, PreschoolFemaleGene DosageGlutathione Transferase/genetics/metabolismHaplotypesHematopoietic Stem Cell TransplantationHumansInfantMaleMyeloablative Agonists/administration & dosage/pharmacokineticsTransplantation Conditioning
PMID: 23292236
Full text
Article (Published version) (682 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Plateforme d'oncologie et d'hématologie pédiatrique (907)
(ISO format)
ANSARI DJABERI, Marc Georges et al. Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients. In: Bone Marrow Transplantation, 2013, vol. 48, n° 7, p. 939-46. https://archive-ouverte.unige.ch/unige:35601

305 hits

1 download


Deposited on : 2014-04-09

Export document
Format :
Citation style :